Skip to main content

Table 2 Number, sales volume (in billion Standard Units), and proportion (%) of FDCs and single drugs (SDs) on the Indian antibiotic market, 2008–2020

From: Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics

  

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

FDCs

No.

114

115

119

122

124

121

123

119

119

118

116

116

112

Vol

3.7

4.0

4.2

4.5

4.8

5.3

5.5

5.9

5.6

5.3

5.0

4.9

4.5

32.9%

33.6%

33.9%

35.2%

36.8%

37.8%

40.0%

41.6%

39.5%

39.2%

37.7%

36.9%

37.3%

SDs

No.

78

78

77

79

77

79

80

78

76

77

77

78

79

Vol

7.5

7.8

8.3

8.2

8.3

8.8

8.3

8.3

8.5

8.2

8.3

8.4

7.6

67.1%

66.4%%

66.1%%

64.8%

63.2%

62.3%%

60.0%%

58.4%

60.5%%

60.8%

62.3

63.19%

62.7%

Total

Vol

11.1

11.8

12.5

12.7

13.1

14.2

13.8

14.2

14.1

13.4

13.2

13.3

12.1